share_log

山東新華製藥股份:海外監管公告-關於全資子公司頭孢克洛膠囊通過仿製藥一致性評價的公告

SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Cefaclor Capsules of Wholly-owned Subsidiary Passing the Generics Consistency Evaluation

Hong Kong Stock Exchange ·  Apr 10 04:37
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more